Press Releases

Press Releases

Applied Molecular Transport Announces Upcoming Investor Events in September and October

Sep 17, 2021
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company will participate in the following investor events in September and October.

Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors

Aug 24, 2021
SOUTH SAN FRANCISCO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of Holly Schachner, M.D. a seasoned and accomplished industry veteran to its Board of Directors.

Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Aug 10, 2021
Top-line data readouts expected from four Phase 2 trials of oral AMT-101, consistent with previous guidance Combination trial of AMT-101 with anti-TNF α in moderate-to-severe ulcerative colitis (UC) patients in the fourth quarter of 2021; Monotherapy trial in pouchitis, combination trial with

Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference

Aug 05, 2021
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during Canaccord

Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress

Jul 09, 2021
Once daily, oral AMT-101 was safe and well tolerated, and demonstrated trends of improvement in objective measures of inflammation: fecal calprotectin, CRP, and histology Key findings support oral AMT-101 actively exerts immunomodulatory effect resulting in local and systemic benefit Microbiome

Applied Molecular Transport to Present at JMP Securities Life Sciences Conference

Jun 09, 2021
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the JMP

Applied Molecular Transport to Present at Jefferies Virtual Healthcare Conference

May 26, 2021
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the

Applied Molecular Transport Reports First Quarter 2021 Financial Results and Provides Corporate Update

May 13, 2021
Enrollment ongoing in each of oral AMT-101’s four Phase 2 trials On track to announce oral AMT-101 top-line data readouts from the four Phase 2 trials, being conducted in multiple ulcerative colitis populations and rheumatoid arthritis, beginning in the second half of 2021 and into 2022 Expanded

Applied Molecular Transport to Present at BofA Securities 2021 Health Care Conference

May 06, 2021
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the BofA

Applied Molecular Transport Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Apr 06, 2021
SOUTH SAN FRANCISCO, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 2,875,000 shares of its common stock, which

Displaying 1 - 10 of 18